Bombus terrestris chromosome 16, iyBomTerr1.2, whole genome shotgun sequence.
Bombus terrestris (buff-tailed bumblebee)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Bombus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342936.1.\nAssembly name: iyBomTerr1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUYY000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus terrestris Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC100643221, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC100643221, transcript variant X1
centrosomal protein of 131 kDa, transcript variant X6
centrosomal protein of 131 kDa, transcript variant X5
centrosomal protein of 131 kDa, transcript variant X3
centrosomal protein of 131 kDa, transcript variant X4
centrosomal protein of 131 kDa, transcript variant X2
centrosomal protein of 131 kDa, transcript variant X1
centrosomal protein of 131 kDa, transcript variant X7
centrosomal protein of 131 kDa, transcript variant X8
centrosomal protein of 131 kDa, transcript variant X10
centrosomal protein of 131 kDa isoform X1
centrosomal protein of 131 kDa isoform X3
centrosomal protein of 131 kDa isoform X5
centrosomal protein of 131 kDa isoform X2
centrosomal protein of 131 kDa, transcript variant X9
centrosomal protein of 131 kDa isoform X4
basic-leucine zipper transcription factor A, transcript variant X1
basic-leucine zipper transcription factor A, transcript variant X2
basic-leucine zipper transcription factor A, transcript variant X4
basic-leucine zipper transcription factor A, transcript variant X5
basic-leucine zipper transcription factor A isoform X1
basic-leucine zipper transcription factor A isoform X2
basic-leucine zipper transcription factor A isoform X4
basic-leucine zipper transcription factor A isoform X5
basic-leucine zipper transcription factor A, transcript variant X3
basic-leucine zipper transcription factor A isoform X3
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X6
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X9
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X8
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X10
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 12, transcript variant X7
disintegrin and metalloproteinase domain-containing protein 19 isoform X4
uncharacterized protein LOC100644271 isoform X6
uncharacterized protein LOC100644271 isoform X1
disintegrin and metalloproteinase domain-containing protein 12 isoform X9
uncharacterized protein LOC100644271 isoform X3
disintegrin and metalloproteinase domain-containing protein 19 isoform X8
disintegrin and metalloproteinase domain-containing protein 19 isoform X10
uncharacterized protein LOC100644271 isoform X5
uncharacterized protein LOC100644271 isoform X2
disintegrin and metalloproteinase domain-containing protein 19 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein phosphatase PTC7 homolog, transcript variant X4
protein phosphatase PTC7 homolog isoform X4
protein phosphatase PTC7 homolog, transcript variant X2
protein phosphatase PTC7 homolog, transcript variant X3
protein phosphatase PTC7 homolog, transcript variant X1
protein phosphatase PTC7 homolog isoform X1
protein phosphatase PTC7 homolog isoform X2
protein phosphatase PTC7 homolog isoform X3
probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase, transcript variant X2
probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase, transcript variant X1
probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase isoform X2
probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase isoform X1
guanine nucleotide-binding protein G(o) subunit alpha
ran-binding protein 9, transcript variant X1
ran-binding protein 9, transcript variant X2
ran-binding protein 9, transcript variant X3
AN1-type zinc finger protein 2A, transcript variant X1
AN1-type zinc finger protein 2A, transcript variant X2
ras-related protein Rab-18, transcript variant X3
ras-related protein Rab-18, transcript variant X2
ras-related protein Rab-18, transcript variant X1
ras-related protein Rab-18, transcript variant X4
ras-related protein Rab-18, transcript variant X5
uncharacterized LOC100643911, transcript variant X2
uncharacterized LOC100643911, transcript variant X1
uncharacterized protein LOC100643911 isoform X1
uncharacterized protein LOC100643911 isoform X2
pancreatic lipase-related protein 2, transcript variant X1
pancreatic lipase-related protein 2, transcript variant X2
pancreatic lipase-related protein 2, transcript variant X3
pancreatic lipase-related protein 2 isoform X1
pancreatic lipase-related protein 2 isoform X2
pancreatic lipase-related protein 2 isoform X3
uncharacterized LOC100651224, transcript variant X2
uncharacterized LOC100651224, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC100651224, transcript variant X1
uncharacterized LOC100651224, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC100651224, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC100651224, transcript variant X7
uncharacterized LOC100651224, transcript variant X4
uncharacterized LOC100651224, transcript variant X8
uncharacterized LOC100651224, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC100651224, transcript variant X11
uncharacterized LOC100651224, transcript variant X9
polypyrimidine tract-binding protein 2, transcript variant X9
polypyrimidine tract-binding protein 2, transcript variant X11
polypyrimidine tract-binding protein 2, transcript variant X4
polypyrimidine tract-binding protein 2, transcript variant X14
polypyrimidine tract-binding protein 2, transcript variant X16
polypyrimidine tract-binding protein 2, transcript variant X19
polypyrimidine tract-binding protein 2, transcript variant X2
polypyrimidine tract-binding protein 2 isoform X8
polypyrimidine tract-binding protein 2, transcript variant X1
polypyrimidine tract-binding protein 2, transcript variant X5
polypyrimidine tract-binding protein 2, transcript variant X6
polypyrimidine tract-binding protein 2, transcript variant X8
polypyrimidine tract-binding protein 2, transcript variant X15
polypyrimidine tract-binding protein 2, transcript variant X17
polypyrimidine tract-binding protein 2, transcript variant X18
polypyrimidine tract-binding protein 2, transcript variant X12
polypyrimidine tract-binding protein 1 isoform X9
polypyrimidine tract-binding protein 2, transcript variant X3
polypyrimidine tract-binding protein 2 isoform X1
polypyrimidine tract-binding protein 1 isoform X2
polypyrimidine tract-binding protein 1 isoform X3
polypyrimidine tract-binding protein 2 isoform X5
polypyrimidine tract-binding protein 2, transcript variant X10
polypyrimidine tract-binding protein 2, transcript variant X13
polypyrimidine tract-binding protein 2 isoform X7
polypyrimidine tract-binding protein 2 isoform X10
polypyrimidine tract-binding protein 2, transcript variant X7
polypyrimidine tract-binding protein 2 isoform X4
polypyrimidine tract-binding protein 2 isoform X6
polypyrimidine tract-binding protein 2 isoform X11
polypyrimidine tract-binding protein 2, transcript variant X20
polypyrimidine tract-binding protein 2 isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cuticle protein 18.7, transcript variant X1
cuticle protein 18.7, transcript variant X3
cuticle protein 18.7, transcript variant X2
myb-like protein X, transcript variant X8
myb-like protein X, transcript variant X5
myb-like protein X, transcript variant X2
myb-like protein X, transcript variant X6
myb-like protein X, transcript variant X7
myb-like protein X, transcript variant X4
myb-like protein X, transcript variant X3
myb-like protein X, transcript variant X1
myb-like protein X, transcript variant X9
myb-like protein X, transcript variant X10
serine-rich adhesin for platelets isoform X2
serine-rich adhesin for platelets isoform X1
probable rRNA-processing protein EBP2 homolog
uncharacterized LOC100643304, transcript variant X2
uncharacterized LOC100643304, transcript variant X1
uncharacterized LOC100643304, transcript variant X5
uncharacterized LOC100643304, transcript variant X3
uncharacterized LOC100643304, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X14
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X11
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X10
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X12
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X13
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X6
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X7
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X5
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X8
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X18
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X17
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X16
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X15
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X19
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X10
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X7
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X8
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X9
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X5
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X6
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X11
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X12
uncharacterized LOC125386512, transcript variant X2
uncharacterized LOC125386512, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105666613, transcript variant X5
uncharacterized LOC105666613, transcript variant X1
uncharacterized LOC105666613, transcript variant X3
uncharacterized LOC105666613, transcript variant X6
uncharacterized LOC105666613, transcript variant X2
uncharacterized LOC105666613, transcript variant X4
uncharacterized protein F13E9.13, mitochondrial, transcript variant X3
uncharacterized protein F13E9.13, mitochondrial isoform X3
uncharacterized protein F13E9.13, mitochondrial, transcript variant X1
uncharacterized protein F13E9.13, mitochondrial, transcript variant X2
uncharacterized protein F13E9.13, mitochondrial isoform X1
uncharacterized protein F13E9.13, mitochondrial isoform X2
tumor protein p53-inducible nuclear protein 2, transcript variant X5
tumor protein p53-inducible nuclear protein 2, transcript variant X3
tumor protein p53-inducible nuclear protein 2, transcript variant X7
tumor protein p53-inducible nuclear protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 119 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2, transcript variant X1
tumor protein p53-inducible nuclear protein 2, transcript variant X2
tumor protein p53-inducible nuclear protein 2 isoform X1
tumor protein p53-inducible nuclear protein 2 isoform X2
tumor protein p53-inducible nuclear protein 2 isoform X5
tumor protein p53-inducible nuclear protein 2 isoform X6
tumor protein p53-inducible nuclear protein 2, transcript variant X4
tumor protein p53-inducible nuclear protein 2 isoform X3
tumor protein p53-inducible nuclear protein 2 isoform X4
activated Cdc42 kinase Ack, transcript variant X3
activated Cdc42 kinase Ack, transcript variant X1
activated Cdc42 kinase Ack, transcript variant X2
ecdysone receptor, transcript variant X2
ecdysone receptor, transcript variant X4
ecdysone receptor, transcript variant X1
ecdysone receptor, transcript variant X3
ecdysone receptor, transcript variant X5
ecdysone receptor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
homeobox protein ceh-17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC105666610, transcript variant X2
uncharacterized LOC105666610, transcript variant X1
uncharacterized LOC105666610, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
homeobox protein ceh-17, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homeobox protein ceh-17, transcript variant X5
homeobox protein ceh-17, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
homeobox protein ceh-17, transcript variant X3
homeobox protein ceh-17, transcript variant X2
homeobox protein ceh-17, transcript variant X4
muscle LIM protein 1, transcript variant X1
muscle LIM protein 1, transcript variant X2
muscle LIM protein 1, transcript variant X3
muscle LIM protein 1, transcript variant X4
muscle LIM protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
muscle LIM protein 1, transcript variant X6
muscle LIM protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
muscle LIM protein 1, transcript variant X8
muscle LIM protein 1, transcript variant X9
uncharacterized LOC110120005, transcript variant X1
uncharacterized LOC110120005, transcript variant X3
uncharacterized LOC110120005, transcript variant X2
brahma-associated protein of 60 kDa, transcript variant X1
brahma-associated protein of 60 kDa, transcript variant X2
brahma-associated protein of 60 kDa isoform X1
brahma-associated protein of 60 kDa isoform X2
protein phosphatase 1 regulatory subunit 14B, transcript variant X4
protein phosphatase 1 regulatory subunit 14B isoform X3
protein phosphatase 1 regulatory subunit 14B, transcript variant X3
protein phosphatase 1 regulatory subunit 14B, transcript variant X1
protein phosphatase 1 regulatory subunit 14B, transcript variant X2
protein phosphatase 1 regulatory subunit 14B isoform X2
protein phosphatase 1 regulatory subunit 14B isoform X1
60S ribosomal protein L31, transcript variant X1
60S ribosomal protein L31, transcript variant X2
THO complex subunit 2, transcript variant X3
THO complex subunit 2, transcript variant X1
THO complex subunit 2, transcript variant X2
DNA repair protein complementing XP-C cells homolog, transcript variant X2
DNA repair protein complementing XP-C cells homolog, transcript variant X1
DNA repair protein complementing XP-C cells homolog isoform X2
DNA repair protein complementing XP-C cells homolog isoform X1
uncharacterized LOC105666608, transcript variant X1
uncharacterized LOC105666608, transcript variant X2
carbohydrate sulfotransferase 4, transcript variant X4
carbohydrate sulfotransferase 4, transcript variant X2
carbohydrate sulfotransferase 4, transcript variant X1
carbohydrate sulfotransferase 4, transcript variant X3
carbohydrate sulfotransferase 4 isoform X2
carbohydrate sulfotransferase 4 isoform X1
beta-1,4-glucuronyltransferase 1, transcript variant X1
beta-1,4-glucuronyltransferase 1, transcript variant X2
uncharacterized LOC100644827, transcript variant X2
uncharacterized LOC100644827, transcript variant X1
uncharacterized LOC125386550, transcript variant X3
uncharacterized LOC125386550, transcript variant X2
uncharacterized LOC125386550, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC100644582, transcript variant X1
uncharacterized LOC100644582, transcript variant X2
uncharacterized protein LOC100644582 isoform X1
uncharacterized protein LOC100644582 isoform X2
uncharacterized LOC100648417, transcript variant X2
uncharacterized LOC100648417, transcript variant X1
101 kDa malaria antigen-like, transcript variant X1
101 kDa malaria antigen-like, transcript variant X2
101 kDa malaria antigen-like, transcript variant X3
uncharacterized LOC105666606, transcript variant X2
uncharacterized LOC105666606, transcript variant X1
uncharacterized LOC105666606, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
sterol regulatory element-binding protein cleavage-activating protein, transcript variant X2
sterol regulatory element-binding protein cleavage-activating protein, transcript variant X1
sterol regulatory element-binding protein cleavage-activating protein, transcript variant X3
sterol regulatory element-binding protein cleavage-activating protein
uncharacterized LOC105666954, transcript variant X2
uncharacterized LOC105666954, transcript variant X4
uncharacterized LOC105666954, transcript variant X1
uncharacterized LOC105666954, transcript variant X3
uncharacterized LOC105666954, transcript variant X5
facilitated trehalose transporter Tret1, transcript variant X1
facilitated trehalose transporter Tret1 isoform X1
facilitated trehalose transporter Tret1, transcript variant X2
facilitated trehalose transporter Tret1 isoform X2
ras-related protein Rab-3, transcript variant X4
ras-related protein Rab-3, transcript variant X1
ras-related protein Rab-3, transcript variant X2
ras-related protein Rab-3, transcript variant X3
uncharacterized LOC100649910, transcript variant X1
uncharacterized LOC100649910, transcript variant X2
uncharacterized LOC100649910, transcript variant X4
uncharacterized LOC100649910, transcript variant X5
uncharacterized LOC100649910, transcript variant X3
uncharacterized protein LOC100649910 isoform X1
uncharacterized protein LOC100649910 isoform X2
uncharacterized protein LOC100649910 isoform X4
uncharacterized protein LOC100649910 isoform X5
uncharacterized protein LOC100649910 isoform X3
chitinase-like protein Idgf4, transcript variant X2
chitinase-like protein Idgf4, transcript variant X1
Golgi integral membrane protein 4, transcript variant X2
Golgi integral membrane protein 4, transcript variant X1
Golgi integral membrane protein 4 isoform X2
Golgi integral membrane protein 4 isoform X1
uncharacterized LOC100649677, transcript variant X1
uncharacterized LOC100649677, transcript variant X2
uncharacterized protein LOC100649677 isoform X1
uncharacterized protein LOC100649677 isoform X2
dynamin-like 120 kDa protein, mitochondrial, transcript variant X7
dynamin-like 120 kDa protein, mitochondrial, transcript variant X1
dynamin-like 120 kDa protein, mitochondrial, transcript variant X3
dynamin-like 120 kDa protein, mitochondrial, transcript variant X2
dynamin-like 120 kDa protein, mitochondrial, transcript variant X5
dynamin-like 120 kDa protein, mitochondrial, transcript variant X6
dynamin-like 120 kDa protein, mitochondrial, transcript variant X4
dynamin-like 120 kDa protein, mitochondrial isoform X1
dynamin-like 120 kDa protein, mitochondrial isoform X3
dynamin-like 120 kDa protein, mitochondrial isoform X2
dynamin-like 120 kDa protein, mitochondrial isoform X4
dynamin-like 120 kDa protein, mitochondrial isoform X5
dynamin-like 120 kDa protein, mitochondrial isoform X6
dynamin-like 120 kDa protein, mitochondrial isoform X7
transmembrane protein 184C, transcript variant X3
transmembrane protein 184C, transcript variant X1
transmembrane protein 184C, transcript variant X2
zinc finger protein 354A, transcript variant X2
zinc finger protein 354A, transcript variant X1
zinc finger protein 354A, transcript variant X3
Bardet-Biedl syndrome 7 protein homolog, transcript variant X4
Bardet-Biedl syndrome 7 protein homolog, transcript variant X1
Bardet-Biedl syndrome 7 protein homolog, transcript variant X2
Bardet-Biedl syndrome 7 protein homolog, transcript variant X6
Bardet-Biedl syndrome 7 protein homolog, transcript variant X3
Bardet-Biedl syndrome 7 protein homolog, transcript variant X5
Bardet-Biedl syndrome 7 protein homolog isoform X5
Bardet-Biedl syndrome 7 protein homolog isoform X2
Bardet-Biedl syndrome 7 protein homolog isoform X6
Bardet-Biedl syndrome 7 protein homolog isoform X3
Bardet-Biedl syndrome 7 protein homolog isoform X1
Bardet-Biedl syndrome 7 protein homolog isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
N66 matrix protein, transcript variant X5
N66 matrix protein, transcript variant X2
N66 matrix protein, transcript variant X3
N66 matrix protein, transcript variant X4
N66 matrix protein, transcript variant X1
uncharacterized LOC110120201, transcript variant X5
uncharacterized LOC110120201, transcript variant X1
uncharacterized LOC110120201, transcript variant X2
uncharacterized LOC110120201, transcript variant X4
uncharacterized LOC110120201, transcript variant X3
unconventional prefoldin RPB5 interactor-like protein, transcript variant X2
unconventional prefoldin RPB5 interactor-like protein, transcript variant X1
unconventional prefoldin RPB5 interactor-like protein isoform X2
unconventional prefoldin RPB5 interactor-like protein isoform X1
alanine aminotransferase 1, transcript variant X1
alanine aminotransferase 1, transcript variant X3
alanine aminotransferase 1, transcript variant X2
brefeldin A-inhibited guanine nucleotide-exchange protein 1, transcript variant X2
brefeldin A-inhibited guanine nucleotide-exchange protein 1, transcript variant X1
brefeldin A-inhibited guanine nucleotide-exchange protein 1
intraflagellar transport protein 172 homolog
corticotropin-releasing factor-binding protein
uncharacterized LOC110120204, transcript variant X2
uncharacterized LOC110120204, transcript variant X1
uncharacterized LOC110120204, transcript variant X3
adenomatous polyposis coli protein, transcript variant X1
adenomatous polyposis coli protein isoform X1
adenomatous polyposis coli protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 106 samples with support for all annotated introns
adenomatous polyposis coli protein isoform X2
AN1-type zinc finger protein 5, transcript variant X2
AN1-type zinc finger protein 5, transcript variant X4
AN1-type zinc finger protein 5, transcript variant X3
AN1-type zinc finger protein 5, transcript variant X1
AN1-type zinc finger protein 5, transcript variant X5
vacuolar protein sorting-associated protein 72 homolog
ras-related protein Rab-11A, transcript variant X2
ras-related protein Rab-11A, transcript variant X1
ras-related protein Rab-11A, transcript variant X3
probable mitochondrial glutathione transporter SLC25A40
ATP synthase lipid-binding protein, mitochondrial
peroxisome assembly protein 12, transcript variant X1
peroxisome assembly protein 12, transcript variant X2
peroxisome assembly protein 12 isoform X1
peroxisome assembly protein 12 isoform X2
uncharacterized LOC100646088, transcript variant X2
uncharacterized LOC100646088, transcript variant X1
uncharacterized LOC100646088, transcript variant X3
low-density lipoprotein receptor-related protein 2
uncharacterized LOC100645476, transcript variant X3
uncharacterized LOC100645476, transcript variant X4
uncharacterized LOC100645476, transcript variant X1
uncharacterized LOC100645476, transcript variant X2
uncharacterized protein LOC100645476 isoform X3
uncharacterized protein LOC100645476 isoform X2
uncharacterized protein LOC100645476 isoform X4
uncharacterized protein LOC100645476 isoform X1
zinc finger protein 678, transcript variant X2
zinc finger protein 678, transcript variant X1
spindle and kinetochore-associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
spindle and kinetochore-associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
spindle and kinetochore-associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
spindle and kinetochore-associated protein 1 isoform X2
spindle and kinetochore-associated protein 1 isoform X1
spindle and kinetochore-associated protein 1, transcript variant X4
spindle and kinetochore-associated protein 1, transcript variant X5
spindle and kinetochore-associated protein 1 isoform X4
spindle and kinetochore-associated protein 1 isoform X3
transmembrane emp24 domain-containing protein bai, transcript variant X1
transmembrane emp24 domain-containing protein bai, transcript variant X2
transmembrane emp24 domain-containing protein bai isoform X1
transmembrane emp24 domain-containing protein bai isoform X2
60S ribosomal protein L37, transcript variant X1
60S ribosomal protein L37, transcript variant X2
translation initiation factor eIF-2B subunit gamma, transcript variant X7
translation initiation factor eIF-2B subunit gamma, transcript variant X4
translation initiation factor eIF-2B subunit gamma, transcript variant X6
translation initiation factor eIF-2B subunit gamma, transcript variant X3
translation initiation factor eIF-2B subunit gamma, transcript variant X1
translation initiation factor eIF-2B subunit gamma, transcript variant X5
translation initiation factor eIF-2B subunit gamma, transcript variant X2
translation initiation factor eIF-2B subunit gamma isoform X1
translation initiation factor eIF-2B subunit gamma isoform X2
translation initiation factor eIF-2B subunit gamma isoform X3
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
beta-1,3-galactosyltransferase 6, transcript variant X2
beta-1,3-galactosyltransferase 6, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial
uncharacterized LOC100643718, transcript variant X3
uncharacterized LOC100643718, transcript variant X1
uncharacterized LOC100643718, transcript variant X4
uncharacterized LOC100643718, transcript variant X2
uncharacterized LOC100643718, transcript variant X5
uncharacterized protein LOC100643718 isoform X1
uncharacterized protein LOC100643718 isoform X4
uncharacterized protein LOC100643718 isoform X2
uncharacterized protein LOC100643718 isoform X5
uncharacterized protein LOC100643718 isoform X3
protein cordon-bleu, transcript variant X1
protein cordon-bleu, transcript variant X2
protein cordon-bleu, transcript variant X7
uncharacterized protein LOC100643472 isoform X1
protein cordon-bleu, transcript variant X4
uncharacterized protein LOC100643472 isoform X4
protein cordon-bleu, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125386580, transcript variant X1
uncharacterized LOC125386580, transcript variant X4
uncharacterized LOC125386580, transcript variant X5
uncharacterized LOC125386580, transcript variant X2
uncharacterized LOC125386580, transcript variant X3
protein cordon-bleu, transcript variant X6
protein cordon-bleu, transcript variant X3
uncharacterized protein LOC100643472 isoform X3
uncharacterized protein LOC100643472 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
basic helix-loop-helix transcription factor amos, transcript variant X2
basic helix-loop-helix transcription factor amos, transcript variant X1
basic helix-loop-helix transcription factor amos isoform X1
basic helix-loop-helix transcription factor amos isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase OSR1, transcript variant X2
serine/threonine-protein kinase OSR1, transcript variant X1
serine/threonine-protein kinase OSR1, transcript variant X3
serine/threonine-protein kinase OSR1 isoform X2
serine/threonine-protein kinase OSR1 isoform X1
serine/threonine-protein kinase OSR1 isoform X3
uncharacterized LOC100643229, transcript variant X3
uncharacterized protein LOC100643229 isoform X3
uncharacterized LOC100643229, transcript variant X4
uncharacterized LOC100643229, transcript variant X1
uncharacterized LOC100643229, transcript variant X2
uncharacterized protein LOC100643229 isoform X1
uncharacterized protein LOC100643229 isoform X2
uncharacterized protein LOC100643229 isoform X4
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
putative sodium-dependent multivitamin transporter
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative sodium-dependent multivitamin transporter
sodium-coupled monocarboxylate transporter 1, transcript variant X3
sodium-coupled monocarboxylate transporter 1, transcript variant X1
sodium-coupled monocarboxylate transporter 1, transcript variant X2
sodium-coupled monocarboxylate transporter 1, transcript variant X4
sodium-coupled monocarboxylate transporter 1
cytoplasmic phosphatidylinositol transfer protein 1
nonsense-mediated mRNA decay factor SMG8
protein brambleberry, transcript variant X2
protein brambleberry, transcript variant X1
uncharacterized LOC100652101, transcript variant X1
uncharacterized LOC100652101, transcript variant X4
uncharacterized LOC100652101, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC100652101, transcript variant X5
uncharacterized LOC100652101, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
uncharacterized LOC100652101, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC100652101, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC100652101, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
uncharacterized LOC105666947, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC105666947, transcript variant X5
uncharacterized LOC105666947, transcript variant X3
uncharacterized LOC105666947, transcript variant X2
uncharacterized LOC105666947, transcript variant X1
uncharacterized LOC125384637, transcript variant X4
uncharacterized LOC125384637, transcript variant X2
uncharacterized LOC125384637, transcript variant X3
uncharacterized LOC125384637, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125386493, transcript variant X3
uncharacterized LOC125386493, transcript variant X2
uncharacterized LOC125386493, transcript variant X1
ATP-binding cassette sub-family F member 2, transcript variant X4
ATP-binding cassette sub-family F member 2, transcript variant X2
ATP-binding cassette sub-family F member 2, transcript variant X3
ATP-binding cassette sub-family F member 2, transcript variant X1
ATP-binding cassette sub-family F member 2, transcript variant X5
ATP-binding cassette sub-family F member 2
uncharacterized LOC100650751, transcript variant X3
uncharacterized LOC100650751, transcript variant X2
uncharacterized LOC100650751, transcript variant X4
uncharacterized LOC100650751, transcript variant X1
uncharacterized protein LOC100650751 isoform X2
uncharacterized protein LOC100650751 isoform X1
cell adhesion molecule 2, transcript variant X6
cell adhesion molecule 2, transcript variant X4
cell adhesion molecule 2, transcript variant X5
cell adhesion molecule 2, transcript variant X1
cell adhesion molecule 2, transcript variant X7
cell adhesion molecule 2, transcript variant X3
cell adhesion molecule 2, transcript variant X2
uncharacterized protein LOC100642355 isoform X1
uncharacterized protein LOC100642355 isoform X2
nucleoporin Nup35, transcript variant X1
nucleoporin Nup35, transcript variant X2
glucose-induced degradation protein 8 homolog
doublesex- and mab-3-related transcription factor A2-like
GTP-binding protein Di-Ras2, transcript variant X2
GTP-binding protein Di-Ras2, transcript variant X1
uncharacterized LOC105666943, transcript variant X3
uncharacterized LOC105666943, transcript variant X2
uncharacterized LOC105666943, transcript variant X1
probable ATP-dependent RNA helicase kurz, transcript variant X1
probable ATP-dependent RNA helicase kurz isoform X1
probable ATP-dependent RNA helicase kurz, transcript variant X2
probable ATP-dependent RNA helicase kurz isoform X2
thioredoxin-related transmembrane protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 119 samples with support for all annotated introns
cytosolic 10-formyltetrahydrofolate dehydrogenase, transcript variant X1
cytosolic 10-formyltetrahydrofolate dehydrogenase, transcript variant X2
cytosolic 10-formyltetrahydrofolate dehydrogenase isoform X1
cytosolic 10-formyltetrahydrofolate dehydrogenase, transcript variant X4
cytosolic 10-formyltetrahydrofolate dehydrogenase, transcript variant X3
cytosolic 10-formyltetrahydrofolate dehydrogenase isoform X2
sex-lethal homolog, transcript variant X1
sex-lethal homolog, transcript variant X3
sex-lethal homolog, transcript variant X2
sex-lethal homolog, transcript variant X4
sex-lethal homolog, transcript variant X7
sex-lethal homolog, transcript variant X6
sex-lethal homolog, transcript variant X5
sex-lethal homolog, transcript variant X10
sex-lethal homolog, transcript variant X8
sex-lethal homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
uncharacterized LOC100649363, transcript variant X5
uncharacterized LOC100649363, transcript variant X3
uncharacterized LOC100649363, transcript variant X2
uncharacterized LOC100649363, transcript variant X1
uncharacterized LOC100649363, transcript variant X4
histone deacetylase 3, transcript variant X1
histone deacetylase 3, transcript variant X2
histone deacetylase 3, transcript variant X3
uncharacterized LOC100648889, transcript variant X2
uncharacterized LOC100648889, transcript variant X1
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
slit homolog 1 protein, transcript variant X3
slit homolog 1 protein, transcript variant X1
slit homolog 1 protein, transcript variant X4
slit homolog 1 protein, transcript variant X2
slit homolog 1 protein, transcript variant X7
slit homolog 1 protein, transcript variant X5
slit homolog 1 protein, transcript variant X6
slit homolog 1 protein, transcript variant X8
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC100648421, transcript variant X2
uncharacterized LOC100648421, transcript variant X1
uncharacterized protein LOC100648421 isoform X1
uncharacterized protein LOC100648421 isoform X2
leucine-rich repeat-containing protein 34
serine/threonine-protein kinase Pink1, mitochondrial
neurogenic locus notch homolog protein 1
uncharacterized LOC100648005, transcript variant X2
uncharacterized LOC100648005, transcript variant X1
uncharacterized protein LOC100648005 isoform X2
uncharacterized protein LOC100648005 isoform X1
ATP-binding cassette sub-family D member 3
TAR DNA-binding protein 43, transcript variant X4
TAR DNA-binding protein 43, transcript variant X3
TAR DNA-binding protein 43, transcript variant X2
TAR DNA-binding protein 43, transcript variant X6
TAR DNA-binding protein 43, transcript variant X7
TAR DNA-binding protein 43, transcript variant X1
TAR DNA-binding protein 43, transcript variant X5
uncharacterized protein LOC100646812 isoform X2
bidirectional sugar transporter N3, transcript variant X1
bidirectional sugar transporter N3, transcript variant X2
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X1
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X3
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X6
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X4
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X5
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X7
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X4
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X1
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X5
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X3
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X6
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X7
ubiquinone biosynthesis O-methyltransferase, mitochondrial
intraflagellar transport protein 81 homolog, transcript variant X1
intraflagellar transport protein 81 homolog, transcript variant X2
intraflagellar transport protein 81 homolog isoform X1
intraflagellar transport protein 81 homolog isoform X2
lysoplasmalogenase-like protein TMEM86A, transcript variant X2
lysoplasmalogenase-like protein TMEM86A, transcript variant X1
lysoplasmalogenase-like protein TMEM86A isoform X2
lysoplasmalogenase-like protein TMEM86A isoform X1
uncharacterized LOC125386499, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
uncharacterized LOC125386499, transcript variant X2
stomatin-like protein 2, mitochondrial, transcript variant X2
stomatin-like protein 2, mitochondrial, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X11
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X9
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X12
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X8
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X10
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X5
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X14
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X7
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X6
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X13
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X17
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X18
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X15
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X21
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X22
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X19
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X20
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X16
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X23
phosphatidylinositol-binding clathrin assembly protein LAP isoform X11
phosphatidylinositol-binding clathrin assembly protein LAP isoform X12
phosphatidylinositol-binding clathrin assembly protein isoform X1
phosphatidylinositol-binding clathrin assembly protein isoform X9
phosphatidylinositol-binding clathrin assembly protein isoform X8
phosphatidylinositol-binding clathrin assembly protein isoform X10
phosphatidylinositol-binding clathrin assembly protein LAP isoform X13
phosphatidylinositol-binding clathrin assembly protein LAP isoform X17
phosphatidylinositol-binding clathrin assembly protein LAP isoform X18
phosphatidylinositol-binding clathrin assembly protein isoform X5
phosphatidylinositol-binding clathrin assembly protein LAP isoform X15
phosphatidylinositol-binding clathrin assembly protein LAP isoform X21
phosphatidylinositol-binding clathrin assembly protein LAP isoform X22
phosphatidylinositol-binding clathrin assembly protein isoform X3
phosphatidylinositol-binding clathrin assembly protein LAP isoform X14
phosphatidylinositol-binding clathrin assembly protein LAP isoform X19
phosphatidylinositol-binding clathrin assembly protein LAP isoform X20
phosphatidylinositol-binding clathrin assembly protein isoform X7
phosphatidylinositol-binding clathrin assembly protein LAP isoform X16
phosphatidylinositol-binding clathrin assembly protein LAP isoform X23
phosphatidylinositol-binding clathrin assembly protein isoform X6
phosphatidylinositol-binding clathrin assembly protein isoform X2
phosphatidylinositol-binding clathrin assembly protein isoform X4
xanthine dehydrogenase/oxidase, transcript variant X1
xanthine dehydrogenase/oxidase isoform X1
xanthine dehydrogenase/oxidase, transcript variant X2
xanthine dehydrogenase/oxidase isoform X2
plasma membrane calcium-transporting ATPase 3, transcript variant X9
plasma membrane calcium-transporting ATPase 3, transcript variant X5
plasma membrane calcium-transporting ATPase 3, transcript variant X1
plasma membrane calcium-transporting ATPase 3, transcript variant X6
plasma membrane calcium-transporting ATPase 3, transcript variant X4
plasma membrane calcium-transporting ATPase 3, transcript variant X7
plasma membrane calcium-transporting ATPase 3, transcript variant X2
plasma membrane calcium-transporting ATPase 3, transcript variant X14
plasma membrane calcium-transporting ATPase 3, transcript variant X13
plasma membrane calcium-transporting ATPase 3, transcript variant X16
plasma membrane calcium-transporting ATPase 3, transcript variant X15
plasma membrane calcium-transporting ATPase 3, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 112 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X17
plasma membrane calcium-transporting ATPase 3, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 117 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X3
plasma membrane calcium-transporting ATPase 3, transcript variant X12
plasma membrane calcium-transporting ATPase 3, transcript variant X8
plasma membrane calcium-transporting ATPase 3, transcript variant X11
plasma membrane calcium-transporting ATPase 3, transcript variant X10
plasma membrane calcium-transporting ATPase 2 isoform X5
plasma membrane calcium-transporting ATPase 2 isoform X4
plasma membrane calcium-transporting ATPase 3 isoform X6
plasma membrane calcium-transporting ATPase 3 isoform X7
plasma membrane calcium-transporting ATPase 3 isoform X9
plasma membrane calcium-transporting ATPase 2 isoform X1
plasma membrane calcium-transporting ATPase 2 isoform X3
plasma membrane calcium-transporting ATPase 2 isoform X2
plasma membrane calcium-transporting ATPase 3 isoform X8
uncharacterized LOC125386497, transcript variant X3
uncharacterized LOC125386497, transcript variant X2
uncharacterized LOC125386497, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
histone PARylation factor 1, transcript variant X1
histone PARylation factor 1, transcript variant X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X1
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X1
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X3
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial isoform X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial isoform X2
leucine-rich repeat-containing protein 4, transcript variant X2
leucine-rich repeat-containing protein 4, transcript variant X1
leucine-rich repeat-containing protein 4 isoform X2
leucine-rich repeat-containing protein 4 isoform X1
protein tramtrack, beta isoform, transcript variant X2
protein tramtrack, beta isoform, transcript variant X1
B-box type zinc finger protein ncl-1, transcript variant X2
B-box type zinc finger protein ncl-1, transcript variant X1
myotubularin-related protein 6, transcript variant X2
myotubularin-related protein 6, transcript variant X3
myotubularin-related protein 6, transcript variant X1
myotubularin-related protein 6 isoform X2
myotubularin-related protein 6 isoform X3
myotubularin-related protein 6 isoform X1
uncharacterized LOC100652146, transcript variant X1
uncharacterized LOC100652146, transcript variant X2
uncharacterized protein LOC100652146 isoform X1
uncharacterized protein LOC100652146 isoform X2
testis-specific serine/threonine-protein kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
40S ribosomal protein S2, transcript variant X1
40S ribosomal protein S2, transcript variant X3
40S ribosomal protein S2, transcript variant X2
probable DNA-directed RNA polymerases I and III subunit RPAC2
myotubularin-related protein DDB_G0290005
thymidylate synthase, transcript variant X2
thymidylate synthase, transcript variant X1
thymidylate synthase, transcript variant X3
probable cationic amino acid transporter, transcript variant X1
probable cationic amino acid transporter isoform X1
probable cationic amino acid transporter, transcript variant X2
probable cationic amino acid transporter, transcript variant X3
cationic amino acid transporter 3 isoform X2
uncharacterized LOC125386536, transcript variant X2
uncharacterized LOC125386536, transcript variant X1
uncharacterized LOC125386536, transcript variant X3
parathyroid hormone/parathyroid hormone-related peptide receptor, transcript variant X2
parathyroid hormone/parathyroid hormone-related peptide receptor, transcript variant X1
parathyroid hormone/parathyroid hormone-related peptide receptor, transcript variant X3
parathyroid hormone/parathyroid hormone-related peptide receptor, transcript variant X5
parathyroid hormone/parathyroid hormone-related peptide receptor isoform X3
parathyroid hormone/parathyroid hormone-related peptide receptor isoform X2
parathyroid hormone/parathyroid hormone-related peptide receptor isoform X1
vasoactive intestinal polypeptide receptor 2 isoform X5
parathyroid hormone/parathyroid hormone-related peptide receptor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
parathyroid hormone/parathyroid hormone-related peptide receptor isoform X4
uncharacterized LOC100645665, transcript variant X1
uncharacterized LOC100645665, transcript variant X2
uncharacterized protein LOC100645665 isoform X2
uncharacterized protein LOC100645665 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
thymic stromal cotransporter homolog, transcript variant X8
thymic stromal cotransporter homolog, transcript variant X4
thymic stromal cotransporter homolog, transcript variant X2
thymic stromal cotransporter homolog, transcript variant X7
thymic stromal cotransporter homolog, transcript variant X1
thymic stromal cotransporter homolog, transcript variant X5
thymic stromal cotransporter homolog, transcript variant X6
thymic stromal cotransporter homolog, transcript variant X3
adenylate cyclase type 6, transcript variant X1
adenylate cyclase type 6, transcript variant X2
adenylate cyclase type 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
uncharacterized LOC105666938, transcript variant X3
uncharacterized LOC105666938, transcript variant X2
uncharacterized LOC105666938, transcript variant X1
uncharacterized LOC100645109, transcript variant X2
uncharacterized LOC100645109, transcript variant X1
uncharacterized protein LOC100645109 isoform X1
uncharacterized protein LOC100645109 isoform X2
pancreas transcription factor 1 subunit alpha, transcript variant X2
pancreas transcription factor 1 subunit alpha, transcript variant X1
pancreas transcription factor 1 subunit alpha, transcript variant X3
pancreas transcription factor 1 subunit alpha isoform X3
pancreas transcription factor 1 subunit alpha isoform X2
pancreas transcription factor 1 subunit alpha isoform X1
protein DDI1 homolog 2, transcript variant X1
protein DDI1 homolog 2, transcript variant X2
probable enoyl-CoA hydratase, mitochondrial
uncharacterized LOC100644114, transcript variant X1
uncharacterized LOC100644114, transcript variant X4
uncharacterized LOC100644114, transcript variant X2
uncharacterized LOC100644114, transcript variant X3
uncharacterized protein LOC100644114 isoform X2
uncharacterized protein LOC100644114 isoform X1
uncharacterized LOC100643791, transcript variant X1
uncharacterized LOC100643791, transcript variant X2
uncharacterized protein LOC100643791 isoform X1
uncharacterized protein LOC100643791 isoform X2
E3 ubiquitin-protein ligase TRIM23, transcript variant X2
E3 ubiquitin-protein ligase TRIM23, transcript variant X1
ethanolaminephosphotransferase 1, transcript variant X2
ethanolaminephosphotransferase 1, transcript variant X1
formin-binding protein 4, transcript variant X2
formin-binding protein 4, transcript variant X3
formin-binding protein 4, transcript variant X4
formin-binding protein 4, transcript variant X1
rho GTPase-activating protein 100F, transcript variant X5
rho GTPase-activating protein 100F, transcript variant X2
rho GTPase-activating protein 100F, transcript variant X6
rho GTPase-activating protein 100F, transcript variant X4
rho GTPase-activating protein 100F, transcript variant X3
rho GTPase-activating protein 100F, transcript variant X1
rho GTPase-activating protein 100F isoform X5
rho GTPase-activating protein 100F isoform X2
rho GTPase-activating protein 100F isoform X6
rho GTPase-activating protein 100F isoform X4
rho GTPase-activating protein 100F isoform X3
rho GTPase-activating protein 100F isoform X1
rho GTPase-activating protein 100F, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
rho GTPase-activating protein 100F, transcript variant X9
rho GTPase-activating protein 100F, transcript variant X7
rho GTPase-activating protein 100F isoform X10
rho GTPase-activating protein 100F isoform X7
rho GTPase-activating protein 100F isoform X9
rho GTPase-activating protein 100F, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
rho GTPase-activating protein 100F, transcript variant X11
rho GTPase-activating protein 100F isoform X8
rho GTPase-activating protein 100F isoform X11
uncharacterized LOC125386545, transcript variant X1
uncharacterized LOC125386545, transcript variant X2
alpha-mannosidase 2, transcript variant X2
alpha-mannosidase 2, transcript variant X3
alpha-mannosidase 2, transcript variant X7
alpha-mannosidase 2, transcript variant X6
alpha-mannosidase 2, transcript variant X5
alpha-mannosidase 2, transcript variant X1
alpha-mannosidase 2, transcript variant X4
uncharacterized LOC110120207, transcript variant X1
uncharacterized LOC110120207, transcript variant X2
serine protease inhibitor dipetalogastin, transcript variant X3
serine protease inhibitor dipetalogastin, transcript variant X2
serine protease inhibitor dipetalogastin isoform X3
serine protease inhibitor dipetalogastin isoform X2
serine protease inhibitor dipetalogastin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine protease inhibitor dipetalogastin isoform X1
coatomer subunit beta', transcript variant X2
coatomer subunit beta', transcript variant X1
coatomer subunit beta', transcript variant X3
forkhead box protein D1, transcript variant X3
forkhead box protein D1, transcript variant X2
forkhead box protein D1, transcript variant X1
dnaJ homolog subfamily C member 11, transcript variant X2
dnaJ homolog subfamily C member 11, transcript variant X1
dnaJ homolog subfamily C member 11 isoform X1
dnaJ homolog subfamily C member 11 isoform X2
uncharacterized protein C1orf50 homolog, transcript variant X3
uncharacterized protein C1orf50 homolog, transcript variant X2
uncharacterized protein C1orf50 homolog, transcript variant X1
uncharacterized protein C1orf50 homolog isoform X3
uncharacterized protein C1orf50 homolog isoform X2
uncharacterized protein C1orf50 homolog isoform X1
uncharacterized protein LOC100651063 isoform X2
INO80 complex subunit E, transcript variant X1
INO80 complex subunit E, transcript variant X2
INO80 complex subunit E, transcript variant X4
INO80 complex subunit E, transcript variant X3
INO80 complex subunit E, transcript variant X5
E3 ubiquitin-protein ligase MARCHF3-like, transcript variant X1
E3 ubiquitin-protein ligase MARCHF3-like isoform X1
E3 ubiquitin-protein ligase MARCHF3-like, transcript variant X2
E3 ubiquitin-protein ligase MARCHF3-like isoform X2
sin3 histone deacetylase corepressor complex component SDS3
coiled-coil domain-containing protein 50, transcript variant X1
coiled-coil domain-containing protein 50, transcript variant X2
coiled-coil domain-containing protein 50 isoform X2
coiled-coil domain-containing protein 50 isoform X1
protein-S-isoprenylcysteine O-methyltransferase
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X4
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X3
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X14
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X13
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X12
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X10
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X7
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X9
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X6
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X11
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X8
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X5
basement membrane-specific heparan sulfate proteoglycan core protein isoform X1
basement membrane-specific heparan sulfate proteoglycan core protein isoform X14
basement membrane-specific heparan sulfate proteoglycan core protein isoform X13
basement membrane-specific heparan sulfate proteoglycan core protein isoform X12
basement membrane-specific heparan sulfate proteoglycan core protein isoform X10
basement membrane-specific heparan sulfate proteoglycan core protein isoform X7
basement membrane-specific heparan sulfate proteoglycan core protein isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein isoform X9
basement membrane-specific heparan sulfate proteoglycan core protein isoform X6
basement membrane-specific heparan sulfate proteoglycan core protein isoform X3
basement membrane-specific heparan sulfate proteoglycan core protein isoform X11
basement membrane-specific heparan sulfate proteoglycan core protein isoform X8
basement membrane-specific heparan sulfate proteoglycan core protein isoform X5
basement membrane-specific heparan sulfate proteoglycan core protein isoform X2
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X15
basement membrane-specific heparan sulfate proteoglycan core protein isoform X15
targeting protein for Xklp2, transcript variant X1
targeting protein for Xklp2, transcript variant X3
leucine-rich repeat flightless-interacting protein 2, transcript variant X3
leucine-rich repeat flightless-interacting protein 2, transcript variant X2
leucine-rich repeat flightless-interacting protein 2, transcript variant X1
leucine-rich repeat flightless-interacting protein 2 isoform X1
leucine-rich repeat flightless-interacting protein 2 isoform X2
targeting protein for Xklp2, transcript variant X2
transcription cofactor vestigial-like protein 4, transcript variant X2
transcription cofactor vestigial-like protein 4, transcript variant X1
transcription cofactor vestigial-like protein 4
ubiquitin-like modifier-activating enzyme atg7, transcript variant X1
ubiquitin-like modifier-activating enzyme atg7, transcript variant X2
ubiquitin-like modifier-activating enzyme atg7, transcript variant X3
ubiquitin-like modifier-activating enzyme atg7 isoform X1
ubiquitin-like modifier-activating enzyme atg7 isoform X2
uncharacterized LOC100642588, transcript variant X1
uncharacterized LOC100642588, transcript variant X2
uncharacterized protein LOC100642588 isoform X1
uncharacterized protein LOC100642588 isoform X2
kelch-like ECH-associated protein 1B, transcript variant X2
kelch-like ECH-associated protein 1B, transcript variant X1
glucoside xylosyltransferase 1, transcript variant X2
glucoside xylosyltransferase 1, transcript variant X1
glucoside xylosyltransferase 1 isoform X1
glucoside xylosyltransferase 1 isoform X2
PDZ domain-containing protein GIPC3, transcript variant X1
PDZ domain-containing protein GIPC3, transcript variant X2
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial
ATP-binding cassette sub-family G member 5, transcript variant X1
ATP-binding cassette sub-family G member 5, transcript variant X2
ATP-binding cassette sub-family G member 5 isoform X2
ATP-binding cassette sub-family G member 5 isoform X1
dual specificity protein phosphatase Mpk3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit
vacuolar protein sorting-associated protein 13D, transcript variant X2
vacuolar protein sorting-associated protein 13D, transcript variant X1
vacuolar protein sorting-associated protein 13D isoform X1
vacuolar protein sorting-associated protein 13D isoform X2
vacuolar protein sorting-associated protein 13D, transcript variant X3
vacuolar protein sorting-associated protein 13D isoform X3
tumor protein p63-regulated gene 1-like protein, transcript variant X1
tumor protein p63-regulated gene 1-like protein, transcript variant X2
tumor protein p63-regulated gene 1-like protein isoform X1
tumor protein p63-regulated gene 1-like protein isoform X2
C1GALT1-specific chaperone 1, transcript variant X1
C1GALT1-specific chaperone 1, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 isoform X2
mitochondrial carrier protein Rim2, transcript variant X2
mitochondrial carrier protein Rim2, transcript variant X3
mitochondrial carrier protein Rim2, transcript variant X1
mitochondrial carrier protein Rim2 isoform X1
mitochondrial carrier protein Rim2, transcript variant X4
mitochondrial carrier protein Rim2 isoform X2
vesicle-fusing ATPase 1, transcript variant X1
vesicle-fusing ATPase 1, transcript variant X2
A-kinase anchor protein 9, transcript variant X1
A-kinase anchor protein 9, transcript variant X9
A-kinase anchor protein 9, transcript variant X11
A-kinase anchor protein 9, transcript variant X8
A-kinase anchor protein 9, transcript variant X10
A-kinase anchor protein 9, transcript variant X12
A-kinase anchor protein 9, transcript variant X13
A-kinase anchor protein 9, transcript variant X3
A-kinase anchor protein 9, transcript variant X7
A-kinase anchor protein 9, transcript variant X2
A-kinase anchor protein 9, transcript variant X6
A-kinase anchor protein 9, transcript variant X4
A-kinase anchor protein 9, transcript variant X5
patched domain-containing protein 3, transcript variant X2
patched domain-containing protein 3, transcript variant X1
patched domain-containing protein 3 isoform X2
patched domain-containing protein 3 isoform X1
uncharacterized LOC110119987, transcript variant X5
uncharacterized LOC110119987, transcript variant X7
uncharacterized LOC110119987, transcript variant X4
uncharacterized LOC100647916, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
uncharacterized LOC100647916, transcript variant X2
uncharacterized LOC110119987, transcript variant X6
uncharacterized LOC110119987, transcript variant X3
uncharacterized LOC110119987, transcript variant X1
uncharacterized LOC110119987, transcript variant X2
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X1
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X6
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X4
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X9
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X7
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X2
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X5
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X3
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X8
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X10
calcium-binding mitochondrial carrier protein Aralar1 isoform X6
calcium-binding mitochondrial carrier protein Aralar1 isoform X5
calcium-binding mitochondrial carrier protein Aralar1 isoform X3
calcium-binding mitochondrial carrier protein Aralar1 isoform X1
calcium-binding mitochondrial carrier protein Aralar1 isoform X2
calcium-binding mitochondrial carrier protein Aralar1 isoform X4
calcium-binding mitochondrial carrier protein Aralar1 isoform X7
dnaJ homolog subfamily B member 6, transcript variant X1
dnaJ homolog subfamily B member 6, transcript variant X3
dnaJ homolog subfamily B member 6, transcript variant X4
dnaJ homolog subfamily B member 6, transcript variant X2
dnaJ homolog subfamily B member 6 isoform X1
dnaJ homolog subfamily B member 6 isoform X2
dnaJ homolog subfamily B member 6 isoform X3
ran-binding protein 3, transcript variant X2
ran-binding protein 3, transcript variant X1
uncharacterized LOC110119990, transcript variant X2
uncharacterized LOC110119990, transcript variant X3
uncharacterized LOC110119990, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 102 samples with support for all annotated introns
glutamate receptor-interacting protein 1
solute carrier family 35 member E1 homolog
uncharacterized LOC100649037, transcript variant X4
uncharacterized LOC100649037, transcript variant X1
uncharacterized LOC100649037, transcript variant X3
uncharacterized LOC100649037, transcript variant X2
uncharacterized protein LOC100649037 isoform X1
uncharacterized protein LOC100649037 isoform X2
uncharacterized LOC110119995, transcript variant X1
uncharacterized LOC110119995, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 4, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 4, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 4, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 4, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 4 isoform X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3
uncharacterized LOC100649600, transcript variant X4
uncharacterized LOC100649600, transcript variant X6
uncharacterized LOC100649600, transcript variant X1
uncharacterized LOC100649600, transcript variant X2
uncharacterized LOC100649600, transcript variant X5
uncharacterized protein LOC100649600 isoform X1
uncharacterized protein LOC100649600 isoform X2
uncharacterized protein LOC100649600 isoform X5
uncharacterized protein LOC100649600 isoform X4
uncharacterized protein LOC100649600 isoform X6
uncharacterized LOC100649600, transcript variant X3
uncharacterized protein LOC100649600 isoform X3
interferon-related developmental regulator 2
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
calcyphosin-like protein, transcript variant X3
calcyphosin-like protein, transcript variant X2
calcyphosin-like protein, transcript variant X1
constitutive coactivator of PPAR-gamma-like protein 1 homolog
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X9
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X10
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X4
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X1
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X6
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X7
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X2
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X5
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X8
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X10
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X9
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X4
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X8
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X6
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X7
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X2
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X5
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X1
ATP-binding cassette sub-family F member 3, transcript variant X1
ATP-binding cassette sub-family F member 3 isoform X1
ATP-binding cassette sub-family F member 3, transcript variant X2
ATP-binding cassette sub-family F member 3 isoform X2
WAS/WASL-interacting protein family member 1
transcription factor Sp4, transcript variant X3
transcription factor Sp4, transcript variant X2
transcription factor Sp4, transcript variant X1
transcription factor Sp4, transcript variant X5
transcription factor Sp4, transcript variant X4
transcription factor Sp4, transcript variant X6
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X4
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X5
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X2
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X1
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X3
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X7
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X6
glycerol-3-phosphate dehydrogenase, mitochondrial isoform X1
glycerol-3-phosphate dehydrogenase, mitochondrial isoform X2
glycerol-3-phosphate dehydrogenase, mitochondrial isoform X4
glycerol-3-phosphate dehydrogenase, mitochondrial isoform X3
uncharacterized LOC100651738, transcript variant X1
uncharacterized LOC100651738, transcript variant X2
uncharacterized protein LOC100651738 isoform X2
uncharacterized protein LOC100651738 isoform X1
dnaJ homolog subfamily C member 7, transcript variant X4
dnaJ homolog subfamily C member 7, transcript variant X2
dnaJ homolog subfamily C member 7, transcript variant X3
dnaJ homolog subfamily C member 7, transcript variant X1
dnaJ homolog subfamily C member 7, transcript variant X5
dnaJ homolog subfamily C member 7 isoform X2
dnaJ homolog subfamily C member 7 isoform X1
eukaryotic translation initiation factor 3 subunit C
vacuolar protein sorting-associated protein 33B
uncharacterized LOC100644504, transcript variant X1
uncharacterized LOC100644504, transcript variant X2
uncharacterized protein LOC100644504 isoform X1
uncharacterized protein LOC100644504 isoform X2
sorting nexin-7-like, transcript variant X2
sorting nexin-7-like, transcript variant X1
DNA-binding protein RFX2, transcript variant X1
DNA-binding protein RFX2, transcript variant X2
DNA-binding protein RFX2, transcript variant X3
DNA-binding protein RFX2, transcript variant X4
traB domain-containing protein, transcript variant X3
traB domain-containing protein, transcript variant X2
traB domain-containing protein, transcript variant X1
traB domain-containing protein, transcript variant X4
traB domain-containing protein isoform X1
traB domain-containing protein isoform X2
traB domain-containing protein, transcript variant X5
traB domain-containing protein, transcript variant X6
traB domain-containing protein isoform X3
traB domain-containing protein isoform X4
histone-lysine N-methyltransferase SETMAR
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nuclear RNA export factor 1, transcript variant X1
nuclear RNA export factor 1, transcript variant X2
GATA-binding factor C, transcript variant X2
GATA-binding factor C, transcript variant X3
GATA-binding factor C, transcript variant X4
GATA-binding factor C, transcript variant X1
U3 small nucleolar ribonucleoprotein protein IMP4
HMG box-containing protein 4, transcript variant X1
HMG box-containing protein 4, transcript variant X3
HMG box-containing protein 4, transcript variant X2
glycine dehydrogenase (decarboxylating), mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
glycine dehydrogenase (decarboxylating), mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
glycine dehydrogenase (decarboxylating), mitochondrial isoform X2
glycine dehydrogenase (decarboxylating), mitochondrial isoform X1
solute carrier family 35 member E3, transcript variant X2
solute carrier family 35 member E3, transcript variant X1
solute carrier family 35 member E3 isoform X2
solute carrier family 35 member E3 isoform X1
nuclear pore complex protein Nup160 homolog, transcript variant X1
nuclear pore complex protein Nup160 homolog isoform X1
nuclear pore complex protein Nup160 homolog, transcript variant X2
nuclear pore complex protein Nup160 homolog isoform X2
uncharacterized LOC100644272, transcript variant X2
uncharacterized LOC100644272, transcript variant X1
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 140 samples with support for all annotated introns
pyrimidine-specific ribonucleoside hydrolase RihA isoform X5
pyrimidine-specific ribonucleoside hydrolase RihA isoform X4
pyrimidine-specific ribonucleoside hydrolase RihA isoform X3
pyrimidine-specific ribonucleoside hydrolase RihA isoform X2
pyrimidine-specific ribonucleoside hydrolase RihA isoform X1
protein transport protein Sec61 subunit alpha
integrator complex subunit 5, transcript variant X1
integrator complex subunit 5, transcript variant X2
uncharacterized LOC100645102, transcript variant X2
uncharacterized LOC100645102, transcript variant X1
uncharacterized LOC100645102, transcript variant X3
uncharacterized LOC100645102, transcript variant X5
uncharacterized LOC100645102, transcript variant X4
uncharacterized LOC100645102, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 94 samples with support for all annotated introns
uncharacterized LOC100645102, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
uncharacterized protein LOC100645102 isoform X1
uncharacterized protein LOC100645102 isoform X2
uncharacterized protein LOC100645102 isoform X4
uncharacterized protein LOC100645102 isoform X3
uncharacterized protein LOC100645102 isoform X5
uncharacterized protein LOC100645102 isoform X6
uncharacterized LOC100646079, transcript variant X1
uncharacterized LOC100646079, transcript variant X2
vacuolar protein sorting-associated protein 37A, transcript variant X1
vacuolar protein sorting-associated protein 37A, transcript variant X2
vacuolar protein sorting-associated protein 37A isoform X1
vacuolar protein sorting-associated protein 37A isoform X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase, transcript variant X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase, transcript variant X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase isoform X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase isoform X1
immunoglobulin domain-containing protein oig-4, transcript variant X2
immunoglobulin domain-containing protein oig-4 isoform X2
immunoglobulin domain-containing protein oig-4, transcript variant X1
immunoglobulin domain-containing protein oig-4 isoform X1
guanine nucleotide-binding protein subunit beta-2
neuralized-like protein 4, transcript variant X1
neuralized-like protein 4, transcript variant X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X8
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X4
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X3
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X7
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X3
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X6
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X5
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X9
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X4
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X5
GRB10-interacting GYF protein 2, transcript variant X4
GRB10-interacting GYF protein 2, transcript variant X1
GRB10-interacting GYF protein 2, transcript variant X3
GRB10-interacting GYF protein 2, transcript variant X2
GRB10-interacting GYF protein 2 isoform X2
GRB10-interacting GYF protein 2 isoform X1
transcription initiation factor TFIID subunit 10
pancreatic triacylglycerol lipase, transcript variant X2
pancreatic triacylglycerol lipase, transcript variant X1
pancreatic triacylglycerol lipase, transcript variant X4
pancreatic triacylglycerol lipase, transcript variant X3
uncharacterized LOC100644084, transcript variant X2
uncharacterized LOC100644084, transcript variant X1
uncharacterized protein LOC100644084 isoform X1
uncharacterized protein LOC100644084 isoform X2
pre-rRNA-processing protein TSR1 homolog, transcript variant X2
pre-rRNA-processing protein TSR1 homolog, transcript variant X1
pre-rRNA-processing protein TSR1 homolog
DNA replication complex GINS protein PSF3
hepatocyte nuclear factor 4-gamma, transcript variant X4
hepatocyte nuclear factor 4-gamma, transcript variant X3
hepatocyte nuclear factor 4-gamma, transcript variant X2
hepatocyte nuclear factor 4-gamma, transcript variant X1
hepatocyte nuclear factor 4-gamma, transcript variant X5
hepatocyte nuclear factor 4-gamma, transcript variant X8
hepatocyte nuclear factor 4-gamma, transcript variant X7
hepatocyte nuclear factor 4-gamma, transcript variant X6
hepatocyte nuclear factor 4-gamma, transcript variant X9
hepatocyte nuclear factor 4-gamma isoform X3
hepatocyte nuclear factor 4-gamma isoform X2
hepatocyte nuclear factor 4-gamma isoform X1
hepatocyte nuclear factor 4-gamma isoform X4
hepatocyte nuclear factor 4-gamma isoform X5
uncharacterized LOC105666623, transcript variant X1
uncharacterized LOC105666623, transcript variant X3
uncharacterized LOC105666623, transcript variant X2
E3 ubiquitin-protein ligase AMFR, transcript variant X1
E3 ubiquitin-protein ligase AMFR, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
ras-related protein Rab-8A, transcript variant X2
ras-related protein Rab-8A, transcript variant X1
uncharacterized LOC110120001, transcript variant X2
uncharacterized LOC110120001, transcript variant X1
muscarinic acetylcholine receptor DM1, transcript variant X3
muscarinic acetylcholine receptor DM1, transcript variant X6
muscarinic acetylcholine receptor DM1, transcript variant X9
muscarinic acetylcholine receptor DM1, transcript variant X8
muscarinic acetylcholine receptor DM1, transcript variant X4
muscarinic acetylcholine receptor DM1, transcript variant X1
muscarinic acetylcholine receptor DM1, transcript variant X2
muscarinic acetylcholine receptor DM1, transcript variant X7
muscarinic acetylcholine receptor DM1, transcript variant X5
muscarinic acetylcholine receptor DM1, transcript variant X10
uncharacterized LOC125386597, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
uncharacterized LOC125386597, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC100649036, transcript variant X2
uncharacterized LOC100649036, transcript variant X3
uncharacterized LOC100649036, transcript variant X1
uncharacterized protein PF3D7_1120600-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
E3 ubiquitin-protein ligase TRAIP, transcript variant X1
E3 ubiquitin-protein ligase TRAIP, transcript variant X2
activator of 90 kDa heat shock protein ATPase homolog 1, transcript variant X2
activator of 90 kDa heat shock protein ATPase homolog 1, transcript variant X1
activator of 90 kDa heat shock protein ATPase homolog 1, transcript variant X3
activator of 90 kDa heat shock protein ATPase homolog 1, transcript variant X4
activator of 90 kDa heat shock protein ATPase homolog 1
cilia and flagella-associated protein 47
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105666625, transcript variant X3
uncharacterized LOC105666625, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC105666625, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
elongation of very long chain fatty acids protein 6, transcript variant X2
elongation of very long chain fatty acids protein 6, transcript variant X1
elongation of very long chain fatty acids protein 6
uncharacterized LOC125386532, transcript variant X2
uncharacterized LOC125386532, transcript variant X1
elongation of very long chain fatty acids protein 6, transcript variant X3
uncharacterized LOC105666626, transcript variant X3
uncharacterized LOC105666626, transcript variant X1
uncharacterized LOC105666626, transcript variant X2
uncharacterized LOC105666627, transcript variant X6
uncharacterized LOC105666627, transcript variant X3
uncharacterized LOC105666627, transcript variant X1
uncharacterized LOC105666627, transcript variant X7
uncharacterized LOC105666627, transcript variant X5
uncharacterized LOC105666627, transcript variant X8
uncharacterized LOC105666627, transcript variant X4
uncharacterized LOC105666627, transcript variant X2
geranylgeranyl transferase type-2 subunit beta
protein-lysine N-methyltransferase EEF2KMT, transcript variant X1
protein-lysine N-methyltransferase EEF2KMT, transcript variant X2
protein-lysine N-methyltransferase EEF2KMT, transcript variant X3
protein-lysine N-methyltransferase EEF2KMT
CUE domain-containing protein 1, transcript variant X4
CUE domain-containing protein 1, transcript variant X2
CUE domain-containing protein 1, transcript variant X3
CUE domain-containing protein 1, transcript variant X1
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
NADPH--cytochrome P450 reductase, transcript variant X1
NADPH--cytochrome P450 reductase isoform X1
NADPH--cytochrome P450 reductase, transcript variant X2
NADPH--cytochrome P450 reductase isoform X2
probable histone-lysine N-methyltransferase CG1716, transcript variant X5
probable histone-lysine N-methyltransferase CG1716, transcript variant X4
probable histone-lysine N-methyltransferase CG1716, transcript variant X2
probable histone-lysine N-methyltransferase CG1716, transcript variant X3
probable histone-lysine N-methyltransferase CG1716 isoform X2
probable histone-lysine N-methyltransferase CG1716, transcript variant X1
probable histone-lysine N-methyltransferase CG1716 isoform X1
probable histone-lysine N-methyltransferase CG1716 isoform X3
activating signal cointegrator 1 complex subunit 1, transcript variant X3
activating signal cointegrator 1 complex subunit 1, transcript variant X2
activating signal cointegrator 1 complex subunit 1, transcript variant X1
activating signal cointegrator 1 complex subunit 1 isoform X3
activating signal cointegrator 1 complex subunit 1 isoform X1
activating signal cointegrator 1 complex subunit 1 isoform X2
uncharacterized LOC105666630, transcript variant X1
uncharacterized LOC105666630, transcript variant X2
uncharacterized protein LOC105666630 isoform X1
uncharacterized LOC105666630, transcript variant X3
uncharacterized protein LOC105666630 isoform X2
eukaryotic initiation factor 4A-I, transcript variant X2
eukaryotic initiation factor 4A-I, transcript variant X3
eukaryotic initiation factor 4A-I, transcript variant X1
eukaryotic translation initiation factor 4E-binding protein, transcript variant X1
eukaryotic translation initiation factor 4E-binding protein, transcript variant X3
eukaryotic translation initiation factor 4E-binding protein, transcript variant X2
eukaryotic translation initiation factor 4E-binding protein
stimulator of interferon genes protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X2
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X5
UTP--glucose-1-phosphate uridylyltransferase isoform X2
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X3
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X1
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X4
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X6
UTP--glucose-1-phosphate uridylyltransferase isoform X3
UTP--glucose-1-phosphate uridylyltransferase isoform X1
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X3
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X1
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X7
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X8
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X2
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X5
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X4
activating molecule in BECN1-regulated autophagy protein 1B, transcript variant X6
activating molecule in BECN1-regulated autophagy protein 1B isoform X1
activating molecule in BECN1-regulated autophagy protein 1B isoform X2
activating molecule in BECN1-regulated autophagy protein 1B isoform X3
2-oxoglutarate and iron-dependent oxygenase JMJD4
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, transcript variant X1
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, transcript variant X2
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, transcript variant X3
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase isoform X1
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase isoform X2
polycomb protein Scm, transcript variant X2
polycomb protein Scm, transcript variant X1
thioredoxin domain-containing protein 9, transcript variant X1
thioredoxin domain-containing protein 9, transcript variant X2
regulator of G-protein signaling 7, transcript variant X1
regulator of G-protein signaling 7, transcript variant X2
regulator of G-protein signaling 7, transcript variant X3
regulator of G-protein signaling 7, transcript variant X4
ras-like protein 2, transcript variant X2
ras-like protein 2, transcript variant X1
ras-like protein 2, transcript variant X3
ras-like protein 2, transcript variant X5
ras-like protein 2, transcript variant X4
mediator of RNA polymerase II transcription subunit 26, transcript variant X3
mediator of RNA polymerase II transcription subunit 26, transcript variant X2
mediator of RNA polymerase II transcription subunit 26, transcript variant X1
mediator of RNA polymerase II transcription subunit 26 isoform X1
mediator of RNA polymerase II transcription subunit 26 isoform X2
mediator of RNA polymerase II transcription subunit 26 isoform X3
forkhead box protein A2-A, transcript variant X2
forkhead box protein A2-A, transcript variant X4
forkhead box protein A2-A, transcript variant X3
forkhead box protein A2-A, transcript variant X1
forkhead box protein A2-A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
uncharacterized LOC125386510, transcript variant X2
uncharacterized LOC125386510, transcript variant X1
uncharacterized LOC100645506, transcript variant X5
uncharacterized LOC100645506, transcript variant X4
uncharacterized LOC100645506, transcript variant X3
uncharacterized LOC100645506, transcript variant X6
uncharacterized LOC100645506, transcript variant X1
uncharacterized LOC100645506, transcript variant X2
uncharacterized protein LOC100645506 isoform X2
uncharacterized protein LOC100645506 isoform X1
uncharacterized LOC100645506, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
uncharacterized protein LOC100645506 isoform X3
28S ribosomal protein S15, mitochondrial
chromatin modification-related protein MEAF6, transcript variant X1
chromatin modification-related protein MEAF6, transcript variant X2
chromatin modification-related protein MEAF6
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase
rap1 GTPase-GDP dissociation stimulator 1-B
60S ribosome subunit biogenesis protein NIP7 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glycine-rich cell wall structural protein
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 5 isoform X1
ectonucleoside triphosphate diphosphohydrolase 5 isoform X2
nucleoside diphosphate phosphatase ENTPD5 isoform X3
mitochondrial 2-oxodicarboxylate carrier, transcript variant X2
mitochondrial 2-oxodicarboxylate carrier, transcript variant X1
mitochondrial 2-oxodicarboxylate carrier
cilia- and flagella-associated protein 157
protein sel-1 homolog 1, transcript variant X2
protein sel-1 homolog 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
protein transport protein Sec24A, transcript variant X1
protein transport protein Sec24A, transcript variant X2
protein transport protein Sec24A, transcript variant X4
protein transport protein Sec24B isoform X1
protein transport protein Sec24A, transcript variant X3
protein transport protein Sec24A isoform X2
calcium uptake protein 1 homolog, mitochondrial, transcript variant X1
calcium uptake protein 1 homolog, mitochondrial, transcript variant X2
calcium uptake protein 1 homolog, mitochondrial isoform X2
calcium uptake protein 1 homolog, mitochondrial isoform X1
ubiquitin carboxyl-terminal hydrolase MINDY-3 homolog, transcript variant X2
ubiquitin carboxyl-terminal hydrolase MINDY-3 homolog, transcript variant X1
ubiquitin carboxyl-terminal hydrolase MINDY-3 homolog
trinucleotide repeat-containing gene 6C protein isoform X6
sodium-independent sulfate anion transporter, transcript variant X3
sodium-independent sulfate anion transporter, transcript variant X2
sodium-independent sulfate anion transporter, transcript variant X7
sodium-independent sulfate anion transporter, transcript variant X6
sodium-independent sulfate anion transporter, transcript variant X5
sodium-independent sulfate anion transporter isoform X2
sodium-independent sulfate anion transporter, transcript variant X4
sodium-independent sulfate anion transporter isoform X3
sodium-independent sulfate anion transporter, transcript variant X1
sodium-independent sulfate anion transporter isoform X1
sodium-independent sulfate anion transporter isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
autophagy-related protein 9A, transcript variant X3
autophagy-related protein 9A, transcript variant X1
autophagy-related protein 9A, transcript variant X4
autophagy-related protein 9A, transcript variant X2
uncharacterized LOC100649948, transcript variant X2
uncharacterized LOC100649948, transcript variant X1
uncharacterized LOC100649948, transcript variant X10
uncharacterized LOC100649948, transcript variant X6
uncharacterized LOC100649948, transcript variant X16
uncharacterized LOC100649948, transcript variant X8
uncharacterized LOC100649948, transcript variant X11
uncharacterized LOC100649948, transcript variant X12
uncharacterized LOC100649948, transcript variant X15
uncharacterized LOC100649948, transcript variant X17
uncharacterized LOC100649948, transcript variant X3
uncharacterized LOC100649948, transcript variant X5
uncharacterized LOC100649948, transcript variant X14
uncharacterized LOC100649948, transcript variant X4
uncharacterized LOC100649948, transcript variant X13
uncharacterized LOC100649948, transcript variant X9
uncharacterized LOC100649948, transcript variant X18
uncharacterized LOC100649948, transcript variant X7
uncharacterized LOC100649948, transcript variant X19
uncharacterized LOC100649948, transcript variant X20
uncharacterized LOC100649948, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
uncharacterized LOC100649948, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
uncharacterized LOC100649948, transcript variant X22
uncharacterized LOC100649948, transcript variant X23
uncharacterized protein LOC100649948 isoform X1
uncharacterized protein LOC100649948 isoform X9
uncharacterized protein LOC100649948 isoform X5
uncharacterized protein LOC100649948 isoform X15
uncharacterized protein LOC100649948 isoform X7
uncharacterized protein LOC100649948 isoform X10
uncharacterized protein LOC100649948 isoform X11
uncharacterized protein LOC100649948 isoform X14
uncharacterized protein LOC100649948 isoform X16
uncharacterized protein LOC100649948 isoform X2
uncharacterized protein LOC100649948 isoform X4
uncharacterized protein LOC100649948 isoform X13
uncharacterized protein LOC100649948 isoform X3
uncharacterized protein LOC100649948 isoform X12
uncharacterized protein LOC100649948 isoform X8
uncharacterized protein LOC100649948 isoform X17
uncharacterized protein LOC100649948 isoform X6
uncharacterized protein LOC100649948 isoform X18
uncharacterized protein LOC100649948 isoform X19
uncharacterized protein LOC100649948 isoform X23
uncharacterized protein LOC100649948 isoform X20
uncharacterized protein LOC100649948 isoform X21
uncharacterized protein LOC100649948 isoform X22
28S ribosomal protein S22, mitochondrial, transcript variant X1
28S ribosomal protein S22, mitochondrial, transcript variant X2
28S ribosomal protein S22, mitochondrial isoform X2
28S ribosomal protein S22, mitochondrial isoform X1
actin-related protein 8, transcript variant X1
actin-related protein 8, transcript variant X2
uncharacterized LOC105666635, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC105666635, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC105666635, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
uncharacterized LOC105666635, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized protein LOC105666635 isoform X2
uncharacterized protein LOC105666635 isoform X1
uncharacterized protein LOC105666635 isoform X3
uncharacterized LOC100650668, transcript variant X10
uncharacterized LOC100650668, transcript variant X9
uncharacterized LOC100650668, transcript variant X2
uncharacterized LOC100650668, transcript variant X6
uncharacterized LOC100650668, transcript variant X8
uncharacterized LOC100650668, transcript variant X1
uncharacterized LOC100650668, transcript variant X4
uncharacterized LOC100650668, transcript variant X5
uncharacterized LOC100650668, transcript variant X3
uncharacterized LOC100650668, transcript variant X7
uncharacterized LOC100650668, transcript variant X11
uncharacterized LOC100650668, transcript variant X12
uncharacterized protein LOC100650668 isoform X2
uncharacterized protein LOC100650668 isoform X3
uncharacterized protein LOC100650668 isoform X1
uncharacterized protein LOC100650668 isoform X4
uncharacterized protein LOC100650668 isoform X5
uncharacterized protein LOC100650668 isoform X6
uncharacterized protein LOC100650668 isoform X7
exocyst complex component 8, transcript variant X2
exocyst complex component 8, transcript variant X1
nonsense-mediated mRNA decay factor SMG9, transcript variant X4
nonsense-mediated mRNA decay factor SMG9, transcript variant X2
nonsense-mediated mRNA decay factor SMG9, transcript variant X1
nonsense-mediated mRNA decay factor SMG9, transcript variant X3
nonsense-mediated mRNA decay factor SMG9 isoform X1
nonsense-mediated mRNA decay factor SMG9, transcript variant X5
nonsense-mediated mRNA decay factor SMG9 isoform X2
nonsense-mediated mRNA decay factor SMG9 isoform X3
vascular endothelial growth factor receptor 3, transcript variant X3
vascular endothelial growth factor receptor 3, transcript variant X4
vascular endothelial growth factor receptor 3, transcript variant X2
vascular endothelial growth factor receptor 3, transcript variant X1
vascular endothelial growth factor receptor 3 isoform X4
vascular endothelial growth factor receptor 3 isoform X1
vascular endothelial growth factor receptor 3 isoform X2
vascular endothelial growth factor receptor 2 isoform X3
uncharacterized LOC100651820, transcript variant X3
uncharacterized LOC100651820, transcript variant X2
uncharacterized LOC100651820, transcript variant X1
uncharacterized protein LOC100651820 isoform X1
uncharacterized protein LOC100651820 isoform X2
GPI transamidase component PIG-S, transcript variant X1
GPI transamidase component PIG-S, transcript variant X2
GPI transamidase component PIG-S isoform X1
protein I'm not dead yet, transcript variant X3
protein I'm not dead yet, transcript variant X2
protein I'm not dead yet, transcript variant X1
GPI transamidase component PIG-S, transcript variant X3
GPI transamidase component PIG-S isoform X2
uncharacterized LOC100652329, transcript variant X5
uncharacterized LOC100652329, transcript variant X3
uncharacterized LOC100652329, transcript variant X2
uncharacterized LOC100652329, transcript variant X1
uncharacterized LOC100652329, transcript variant X4
uncharacterized LOC100652329, transcript variant X7
uncharacterized LOC100652329, transcript variant X6
uncharacterized LOC100652329, transcript variant X9
uncharacterized LOC100652329, transcript variant X8
uncharacterized LOC100652329, transcript variant X10
uncharacterized protein LOC100652329 isoform X2
uncharacterized protein LOC100652329 isoform X3
uncharacterized protein LOC100652329 isoform X1
uncharacterized protein LOC100652329 isoform X5
uncharacterized protein LOC100652329 isoform X4
uncharacterized protein LOC100652329 isoform X7
uncharacterized protein LOC100652329 isoform X6
uncharacterized protein LOC100652329 isoform X8
protein OPI10 homolog, transcript variant X2
protein OPI10 homolog, transcript variant X1
myotubularin-related protein 3, transcript variant X1
myotubularin-related protein 3, transcript variant X2
myotubularin-related protein 3 isoform X1
myotubularin-related protein 3 isoform X2
gustatory receptor for sugar taste 43a, transcript variant X2
gustatory receptor for sugar taste 43a, transcript variant X1
PAXIP1-associated glutamate-rich protein 1, transcript variant X1
PAXIP1-associated glutamate-rich protein 1, transcript variant X2
PAXIP1-associated glutamate-rich protein 1
uncharacterized protein CG3556, transcript variant X5
uncharacterized protein CG3556, transcript variant X6
uncharacterized protein CG3556, transcript variant X2
uncharacterized protein CG3556, transcript variant X1
uncharacterized protein CG3556, transcript variant X3
uncharacterized protein CG3556, transcript variant X4
uncharacterized LOC125386553, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125386553, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC125386553, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
pre-rRNA-processing protein TSR1 homolog isoform X2
pre-rRNA-processing protein TSR1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC105666750, transcript variant X2
uncharacterized LOC105666750, transcript variant X1
activity-regulated cytoskeleton associated protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
pre-rRNA-processing protein TSR1 homolog, transcript variant X3
uncharacterized LOC105666725, transcript variant X2
uncharacterized LOC105666725, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
retrovirus-related Pol polyprotein from transposon 17.6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
elongation of very long chain fatty acids protein 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 12% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 4, transcript variant X4
piggyBac transposable element-derived protein 4, transcript variant X2
piggyBac transposable element-derived protein 4, transcript variant X1
piggyBac transposable element-derived protein 4, transcript variant X11
piggyBac transposable element-derived protein 4, transcript variant X8
piggyBac transposable element-derived protein 4, transcript variant X3
piggyBac transposable element-derived protein 4, transcript variant X9
piggyBac transposable element-derived protein 4, transcript variant X5
piggyBac transposable element-derived protein 4, transcript variant X6
piggyBac transposable element-derived protein 4, transcript variant X7
piggyBac transposable element-derived protein 4, transcript variant X10
piggyBac transposable element-derived protein 4 isoform X1
piggyBac transposable element-derived protein 4 isoform X2
uncharacterized LOC125386505, transcript variant X2
uncharacterized LOC125386505, transcript variant X3
uncharacterized LOC125386505, transcript variant X4
uncharacterized LOC125386505, transcript variant X5
uncharacterized LOC125386505, transcript variant X6
uncharacterized LOC125386505, transcript variant X1
uncharacterized protein LOC125386505 isoform X1
uncharacterized protein LOC125386505 isoform X2
uncharacterized protein LOC125386505 isoform X3
uncharacterized protein LOC125386505 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns